Xudong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xudong Wang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chengyun Zhang
Faculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China
1 shared publication Chongyang Li
Faculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China
1 shared publicationFuyuan Yang
Health Science Center, Yangtze University, Jingzhou, China
1 shared publication- Haomeng Hu
College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China
1 shared publication - Hongliang Duan
Macao Polytechnic University
1 shared publication - Jingda Li
College of Life Science, Yangtze University, Jingzhou, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (32) , 15550-15565
HFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion
HFGuidedDesign integrates discrete diffusion with HighFold-guided structural feedback to generate cyclic peptide binders from protein sequences, followed by synthesis and SPR validation.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (32) , 15550-15565
Open AccessHFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion
HFGuidedDesign integrates discrete diffusion with HighFold-guided structural feedback to generate cyclic peptide binders from protein sequences, followed by synthesis and SPR validation.
- Top Cited Papers
- 9 March 2021
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 12 (9) , 3898-3918
Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD
Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease. Dietary supplementation has become a promising strategy for managing NAFLD. Hesperetin, a citrus flavonoid, is mainly found in citrus fruits (oranges, grapefruit, and lemons) and possesses multiple pharmacological properties, including anti-cancer, anti-Alzheimer and anti-diabetic effects. However, the anti-NAFLD effect and mechanisms of hesperetin remain unclear. In this study, we investigated the therapeutic effect of hesperetin against NAFLD and the underlying mechanism in vitro and in vivo. In oleic acid (OA)-induced HepG2 cells, hesperetin upregulated antioxidant levels (SOD/GPx/GR/GCLC/HO-1) by triggering the PI3 K/AKT-Nrf2 pathway, alleviating OA-induced reactive oxygen species (ROS) overproduction and hepatotoxicity. Furthermore, hesperetin suppressed NF-κB activation and reduced inflammatory cytokine secretion (TNF-α and IL-6). More importantly, we revealed that this anti-inflammatory effect is attributed to reduced ROS overproduction by the Nrf2 pathway, as pre-treatment with Nrf2 siRNA or an inhibitor of superoxide dismutase (SOD) or/and glutathione peroxidase (GPx) abolished hesperetin-induced NF-κB inactivation and reductions in inflammatory cytokine secretion. In a rat model of high-fat diet (HFD)-induced NAFLD, we confirmed that hesperetin relieved hepatic steatosis, oxidative stress, inflammatory cell infiltration and fibrosis. Moreover, hesperetin activated the PI3 K/AKT-Nrf2 pathway in the liver, increasing antioxidant expression and inhibiting NF-κB activation and inflammatory cytokine secretion. In summary, our results demonstrate that hesperetin ameliorates hepatic oxidative stress through the PI3 K/AKT-Nrf2 pathway and that this antioxidative effect further suppresses NF-κB-mediated inflammation during NAFLD progression. Thus, our study suggests that hesperetin may be an effective dietary supplement for improving NAFLD by suppressing hepatic oxidative stress and inflammation.
- 9 March 2021
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 12 (9) , 3898-3918
Top Cited PapersHesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD
Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disease. Dietary supplementation has become a promising strategy for managing NAFLD. Hesperetin, a citrus flavonoid, is mainly found in citrus fruits (oranges, grapefruit, and lemons) and possesses multiple pharmacological properties, including anti-cancer, anti-Alzheimer and anti-diabetic effects. However, the anti-NAFLD effect and mechanisms of hesperetin remain unclear. In this study, we investigated the therapeutic effect of hesperetin against NAFLD and the underlying mechanism in vitro and in vivo. In oleic acid (OA)-induced HepG2 cells, hesperetin upregulated antioxidant levels (SOD/GPx/GR/GCLC/HO-1) by triggering the PI3 K/AKT-Nrf2 pathway, alleviating OA-induced reactive oxygen species (ROS) overproduction and hepatotoxicity. Furthermore, hesperetin suppressed NF-κB activation and reduced inflammatory cytokine secretion (TNF-α and IL-6). More importantly, we revealed that this anti-inflammatory effect is attributed to reduced ROS overproduction by the Nrf2 pathway, as pre-treatment with Nrf2 siRNA or an inhibitor of superoxide dismutase (SOD) or/and glutathione peroxidase (GPx) abolished hesperetin-induced NF-κB inactivation and reductions in inflammatory cytokine secretion. In a rat model of high-fat diet (HFD)-induced NAFLD, we confirmed that hesperetin relieved hepatic steatosis, oxidative stress, inflammatory cell infiltration and fibrosis. Moreover, hesperetin activated the PI3 K/AKT-Nrf2 pathway in the liver, increasing antioxidant expression and inhibiting NF-κB activation and inflammatory cytokine secretion. In summary, our results demonstrate that hesperetin ameliorates hepatic oxidative stress through the PI3 K/AKT-Nrf2 pathway and that this antioxidative effect further suppresses NF-κB-mediated inflammation during NAFLD progression. Thus, our study suggests that hesperetin may be an effective dietary supplement for improving NAFLD by suppressing hepatic oxidative stress and inflammation.